Research Topics
| A L DunnSummaryAffiliation: Children's Healthcare of Atlanta Country: USA Publications
| Collaborators |
Detail Information
Publications
Radionuclide synovectomy for hemophilic arthropathy: a comprehensive review of safety and efficacy and recommendation for a standardized treatment protocolAmy L Dunn
Department of Pediatrics, Emory University, Atlanta, Georgia 30322, USA
Thromb Haemost 87:383-93. 2002
Arthroscopic synovectomy for hemophilic joint disease in a pediatric populationAmy L Dunn
Department of Pediatrics, AFLAC Cancer and Blood Disorders Center at Children s Healthcare of Atlanta Emory University, Atlanta, Georgia, USA
J Pediatr Orthop 24:414-26. 2004..Complications were rare. Radiographic scores worsened slightly. In this largest analysis of arthroscopic synovectomy for children with hemophilia, rehabilitation was not problematic...
Recent advances in the management of the child who has hemophiliaAmy L Dunn
Aflac Cancer Center and Blood Disorders Service, Department of Pediatrics, Emory University and Children s Healthcare of Atlanta, 2040 Ridgewood Drive NE, Suite 100, Atlanta, GA 30322, USA
Hematol Oncol Clin North Am 18:1249-76, viii. 2004..This article discusses recent advances in the management of the child who has hemophilia...
Management and prevention of recurrent hemarthrosis in patients with hemophiliaAmy L Dunn
Aflac Cancer Center and Blood Disorders Service, Department of Pediatrics, Emory University and Children s Healthcare of Atlanta, GA 30322, USA
Curr Opin Hematol 12:390-4. 2005..Degenerative arthropathy resulting from recurrent hemarthrosis remains the largest source of noninfectious morbidity for persons with hemophilia. Optimal treatment to prevent or reduce joint destruction remains controversial...
Current issues in prophylactic therapy for persons with hemophiliaAmy L Dunn
Aflac Cancer Center and Blood Disorders Service, Department of Pediatrics, Emory University and Children s Healthcare of Atlanta, Atlanta, GA 30322, USA
Acta Haematol 115:162-71. 2006..Individualized treatment is recommended. Collaborative efforts are needed to improve outcomes for all persons with hemophilia...
Recombinant tissue plasminogen activator may reduce frequency of central venous access device infection in hemophilia patients undergoing immune tolerance therapyAmy L Dunn
Comprehensive Hemostasis and Thrombosis Program, Aflac Cancer Center and Blood Disorders Service, Emory University, Atlanta, Georgia, USA
Pediatr Blood Cancer 50:627-9. 2008..Larger randomized trial should be performed in this patient population at high risk of CVAD infection...
Malignancy in patients with haemophilia: a review of the literatureA L Dunn
Aflac Cancer Center and Blood Disorders Service Children s Healthcare of Atlanta Emory University, Atlanta, USA
Haemophilia 16:427-36. 2010..Patients with haemophilia can manifest non infectious related malignancies and symptomatic patients should be evaluated accordingly...
Adenotonsillectomy in patients with desmopressin responsive mild bleeding disorders: a review of the literatureA L Dunn
Aflac Cancer Center and Blood Disorders Service, Emory University, Atlanta, GA 30322, USA
Haemophilia 16:711-6. 2010....
Pathophysiology, diagnosis and prevention of arthropathy in patients with haemophiliaA L Dunn
Children s Healthcare of Atlanta Emory University, Atlanta, GA, USA
Haemophilia 17:571-8. 2011..Efforts to prevent or limit arthropathy include the use of prophylactic factor infusion regimens, surgical joint intervention or both...
